Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A)

被引:18
|
作者
Malhotra-Kumar, Surbhi [1 ]
Mazzariol, Annarita [2 ]
Van Heirstraeten, Liesbet [1 ]
Lammens, Christine [1 ]
de Rijk, Peter [3 ]
Cornaglia, Giuseppe [2 ]
Goossens, Herman [1 ]
机构
[1] Univ Antwerp, Dept Med Microbiol, Vaccine & Infect Dis Inst, B-2610 Antwerp, Belgium
[2] Univ Verona, Dipartimento Patol, Sez Microbiol, I-37100 Verona, Italy
[3] VIB, Dept Mol Genet, Appl Mol Genom Grp, Brussels, Belgium
关键词
SECONDARY STRUCTURE; ERYTHROMYCIN; ATTENUATOR; INDUCTION; BELGIUM; REGION;
D O I
10.1093/jac/dkn432
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We identified erm(A)-harbouring Streptococcus pyogenes that expressed three variant phenotypes: (1) low-level resistance to erythromycin (MICs 1-4 mg/L) but high azithromycin MICs in absolute terms (16-64 mg/L; n = 6); (2) same as (1) but with a high clindamycin MIC (256 mg/L; n = 1); and (3) high-level constitutive MLS (cMLS) resistance (n = 1). Here we analysed the genetic basis of these novel phenotypes. The presence of erm(A) and the absence of macrolide/lincosamide resistance genes erm(B), mef and cfr were confirmed by PCR. erm(A), 23S rRNA, L4 and L22 genes were sequenced. Mutant erm(A) genes were cloned and electrotransformed into the macrolide-susceptible Escherichia coli AG100A. Clonality was determined by emm typing and PFGE. Effects of the identified mutations on free energy changes (Delta G) and putative configurations of the leader sequence were studied in silico. Point mutations (G98A, A137C, C140T and G205A) were observed in the erm(A) regulatory region of all eight erm(A)-harbouring S. pyogenes. Five and two isolates belonged to emm77 and emm89 clones, respectively, and one isolate was an emm1. E. coli transformed with mutant erm(A) harbouring G98A, A137C or C140T mutations (phenotypes 1 and 2) did not express high-level azithromycin or clindamycin resistance. However, cMLS resistance was clearly observed in transformants with erm(A) harbouring both A137C and G205A mutations (phenotype 3). In silico analysis showed that Delta G was minor except for the G205A mutation. Secondary structure predictions further showed that the A137C and G205A mutations together abolished the hairpin sequestering the ribosome-binding and initiation sites of the erm(A) gene, explaining the cMLS phenotype 3. We report point mutations in the erm(A) regulatory region leading to constitutive methylase expression and the presence of additional, as yet unidentified mechanisms mediating high-level azithromycin and clindamycin resistance in erm(A)-harbouring S. pyogenes.
引用
收藏
页码:42 / 46
页数:5
相关论文
共 50 条
  • [1] DISTRIBUTION OF MACROLIDE-RESISTANT GENES AMONG ISOLATES OF MACROLIDE-RESISTANT STREPTOCOCCUS PYOGENES AND STREPTOCOCCUS PNEUMONIAE IN SERBIA
    Gajic, Ina
    Mijac, Vera
    Opavski, Natasa
    Stanojevic, Maja
    Lazarevic, Ivana
    Smitran, Aleksandra
    Hadnadev, Mirjana
    Ranin, L.
    [J]. ARCHIVES OF BIOLOGICAL SCIENCES, 2014, 66 (01) : 93 - 98
  • [2] Macrolide-resistant Streptococcus pyogenes in Norway:: Population structure and resistance determinants
    Littauer, P
    Caugant, DA
    Sangvlk, M
    Hoiby, EA
    Sundsfjord, A
    Simonsen, GS
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (05) : 1896 - 1899
  • [3] Plasmid-borne erm(T) from invasive, macrolide-resistant Streptococcus pyogenes strains
    Woodbury, Robyn L.
    Klammer, Kathryn A.
    Xiong, Yang
    Bailiff, Timothy
    Glennen, Anita
    BartkuS, Joanne M.
    Lynfield, Ruth
    Van Beneden, Chris
    Beall, Bernard W.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (03) : 1140 - 1143
  • [4] Macrolide-resistant Streptococcus pyogenes: prevalence and treatment strategies
    Silva-Costa, Catarina
    Friaes, Ana
    Ramirez, Mario
    Melo-Cristino, Jose
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2015, 13 (05) : 615 - 628
  • [5] Identification of macrolide-resistant clones of Streptococcus pyogenes in Portugal
    Silva-Costa, C.
    Ramirez, M.
    Melo-Cristino, J.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (06) : 513 - 518
  • [6] Clinical isolates of macrolide-resistant Streptococcus pyogenes in Central Greece
    Petinaki, E
    Kontos, F
    Pratti, A
    Skulakis, C
    Maniatis, AN
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 21 (01) : 67 - 70
  • [7] Epidemiology and Molecular Characterization of Macrolide-Resistant Streptococcus pyogenes in Taiwan
    Huang, Chia-Ying
    Lai, Jui-Fen
    Huang, I-Wen
    Chen, Pei-Chen
    Wang, Hui-Ying
    Shiau, Yih-Ru
    Cheng, Ya-Wen
    Hsieh, Li-Yun
    Chang, Shan-Chwen
    Lauderdale, Tsai-Ling Yang
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2014, 52 (02) : 508 - 516
  • [8] Emergence of macrolide-resistant Streptococcus pyogenes strains in French children
    Bingen, E
    Bidet, P
    Mihaila-Amrouche, L
    Doit, C
    Forcet, S
    Brahimi, N
    Bouvet, A
    Cohen, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) : 3559 - 3562
  • [9] Antimicrobial Drug Use and Macrolide-Resistant Streptococcus pyogenes, Belgium
    Van Heirstraeten, Liesbet
    Coenen, Samuel
    Lammens, Christine
    Hens, Niel
    Goossens, Herman
    Malhotra-Kumar, Surbhi
    [J]. EMERGING INFECTIOUS DISEASES, 2012, 18 (09) : 1515 - 1518
  • [10] Tetracycline and macrolide co-resistance in Streptococcus pyogenes:: Co-selection as a reason for increase in macrolide-resistant S-pyogenes?
    Nielsen, HUK
    Hammerum, AM
    Ekelund, K
    Bang, D
    Pallesen, LV
    Frimodt-Moller, N
    [J]. MICROBIAL DRUG RESISTANCE, 2004, 10 (03) : 231 - 238